• Albino, A.P., Sozzi, G., Nanus, D.M., Jhanwar, S.C., and Houghton, A.N. (1992). Malignant transformation of human melanocytes: induction of a complete melanoma phenotype and genotype. Oncogene 7, 23152321.
  • Becher, R., Gibas, Z., Karakousis, C., and Sandberg, A.A. (1983). Nonrandom chromosome changes in malignant melanoma. Cancer Res. 43, 50105016.
  • Hoglund, M., Gisselsson, D., Hansen, G.B., White, V.A., Sall, T., Mitelman, F., and Horsman, D. (2004). Dissecting karyotypic patterns in malignant melanomas: temporal clustering of losses and gains in melanoma karyotypic evolution. Int J Cancer 108, 5765.
  • Kameyama, K., Vieira, W.D., Tsukamoto, K., Law, L.W., and Hearing, V.J. (1990). Differentiation and the tumorigenic and metastatic phenotype of murine melanoma cells. Int. J. Cancer 45, 11511158.
  • Loo, J.C., Liu, L., Hao, A. et al. (2003). Germline splicing mutations of CDKN2A predispose to melanoma. Oncogene 22, 63876394.
  • Rutter, J.L., Goldstein, A.M., Davila, M.R., Tucker, M.A., and Struewing, J.P. (2003). CDKN2A point mutations D153spl(c.457G > T) and IVS2+1G > T result in aberrant splice products affecting both p16(INK4a) and p14(ARF). Oncogene 22, 44444448.
  • Salgia, R., and Skarin, A.T. (1998). Molecular abnormalities in lung cancer. J. Clin. Oncol. 16, 12071217.
  • Schadendorf, D., Fichtner, I., Makki, A., Alijagic, S., Kupper, M., Mrowietz, U., and Henz, B.M. (1996). Metastatic potential of human melanoma cells in nude mice--characterisation of phenotype, cytokine secretion and tumour-associated antigens. Br. J. Cancer 74, 194199.
  • Wich, L.G., Hamilton, H.K., Shapiro, R.L. et al. (2009). Developing a multidisciplinary prospective melanoma biospecimen repository to advance translational research. Am. J. Transl. Res. 1, 3543.
  • Wiese, C., Rolletschek, A., Kania, G., Blyszczuk, P., Tarasov, K.V., Tarasova, Y., Wersto, R.P., Boheler, K.R., and Wobus, A.M. (2004). Nestin expression – a property of multi-lineage progenitor cells? Cell. Mol. Life Sci. 61, 25102522.